FrancisAFarrayeMDMSc

Gastroenterology • Jacksonville, FL

Inflammatory Bowel Disease

Director, Inflammatory Bowel Center, Mayo Clinic, Jacksonville, FL

Join to view full profile

Dr. Farraye is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Farraye's full profile

Already have an account?

Office
4500 San Pablo Rd S
Jacksonville, FL 32224
Phone+1 904-953-2000

Education & Training

Harvard School of Public HealthMSc, 2001
Beth Israel Deaconess Medical CenterFellowship, Gastroenterology, 1986 - 1989
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1982 - 1985
Albert Einstein College of MedicineClass of 1982
SUNY at Stony BrookB.S., 1978

Certifications & Licensure

FL State Medical License 2018 - 2025
MA State Medical License 1984 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2011-2014
Research Mentor of the Year Department of Medicine, Boston University School of Medicine, 2013
Boston University Faculty Development Award Institute for Health Care Improvement, 2013
Boston Magazine Castle Connolly, 2010-2013
Top Doctor U.S. News and World Report, 2011
Fellow (AGAF) American Gastroenterological Association, 2010
Boston University Faculty Development Award: Pocket MBA for Physicians Boston University School of Management, 2010
Best of Boston, Gastroenterology Boston Magazine, 2010
William Carey Award American College of Gastroenterology, 2009
Board of Governors Achievement Award American College of Gastroenterology, 2003
Humanitarian of the Year New England Crohn’s and Colitis Foundation of America, 2003
Presidential Poster Award American College of Gastroenterology, 2002
Ebert Fellowship Harvard Pilgrim Health Care, 1998
Diamond Award Harvard Community Health Plan, 1990
Key Contribution Award Harvard Community Health Plan, 1990, 1993, 1995, 1999
Peer Recognition Award Harvard Community Health Plan, 1986, 1990
Alpha Omega Alpha Albert Einstein College of Medicine, 1982
Medical Student Research Fellowship National Institute of Health, 1981
Research Fellowship American Gastroenterological Association, 1979
Research Fellowship American Liver Foundation, 1979
Scholarship New York State Regents, 1974
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Ileal Pouch-Anal Anastomosis Registry Start of enrollment: 2009 Nov 01
Terminated
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients Start of enrollment: 2011 Oct 01
Completed
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease Start of enrollment: 2014 Feb 01
Completed

Publications & Presentations

PubMed

The Use of Immunomodulators, Biologic Therapies, and Small Molecules in Patients With Inflammatory Bowel Disease and Solid Organ Transplant.
Wissam Ghusn, Fadi H Mourad, Fadi F Francis, Shabana Pasha, Francis A Farraye
Journal of Clinical Gastroenterology. 2025-01-01
Letter: Enhancing the Rigor of Research on Herpes Zoster Risk in IBD Patients Post-SARS-CoV2: Recommendations for Global and Detailed Analyses-Authors' Reply.
Aakash Desai, Francis A Farraye, Freddy Caldera
Inflammatory Bowel Diseases. 2024-12-05
Inadvertent live vaccine administration in adult patients with inflammatory bowel disease on immunosuppressive therapy.
Oscar Ramirez Ramirez, Francis A Farraye, Mary S Hayney, Freddy Caldera
Vaccine. 2024-12-02

Journal Articles

Social Media Use and Preferences in Patients with Inflammatory Bowel Disease
Millie D Long, Francis A Farraye, Inflammatory Bowel Diseases
Immunization Rates and Vaccine Beliefs among Inflammatory Bowel Disease Patients: An Opportunity for Improvement
Wasan SK, Calderwood AH, Long MD, Kappleman MD, Sandler RS, Farraye FA, Inflamm Bowel Dis, 2/1/2014
Recurrent Bell's Palsy in a Patient With Crohn's Disease on Methotrexate
Desalermos AP, Frank S, Farraye FA, J Clin Gastroenterol, 1/31/2014
Nocardia Pneumonia in a Patient with Crohn’s Disease on Infliximab
Saleemuddin A, Govender P, Farraye FA, J Crohns Colitis, 12/13/2013
Cost-Effectiveness of Nonmelanoma Skin Cancer Screening in Patients with Crohn’s Disease
Okafor PN, Stallwood CG, Nguyen L, Sahni D, Cummins DL, Wasan SK, Farraye FA, Erim DO, Inflamm Bowel Dis, 12/1/2013
Is Pyloric Gland Metaplasia in Ileal Pouch Biopsies a Marker for Crohn's Disease?
Agarwal S, Stucchi AF, Dendrinos K, Cerda S, O’Brien M, Becker JM, Heeren T, Farraye FA, Dig Dis Sci, 10/1/2013
Endemic Fungal Infections in IBD When Considering or Using Anti-TNF Antibody Therapy
Ordonez ME, Farraye FA, Di Palma JA, Inflamm Bowel Dis, 10/1/2013
Efficacy and Safety of Natalizumab in Crohn's Disease Patients Treated at Six Boston Academic Hospitals
Juillerat P, Wasan SK, Fowler FA, Pabby VK, Friedman S, Coukos JA, Barto A, Pellish R, Germansky K, Cheifetz A, Korzenik J, Farraye FA, Yajnik V, Inflamm Bowel Dis, 10/1/2013
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, P..., N Engl J Med, 8/22/2013
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A; GEMI..., N Engl J Med, 8/22/2013
Pneumocystis Jiroveci Pneumonia in Inflammatory Bowel Disease: When Should Prophylaxis be Considered?
Okafor PN, Nunes DP, Farraye FA, Inflamm Bowel Dis, 7/1/2013
Plasminogen Activator Inhibitor-1 Is Increased in Colonic Epithelial Cells from Patients with Colitis-associated Cancer
Gillespie E, Leeman SE, Watts LA, Coukos JA, O'Brien MJ, Cerda SR, Farraye FA, Stucchi AF, Becker JM, J Crohns Colitis, 6/1/2013
Polypectomy May Be Adequate Treatment for Adenoma-like Dysplastic Lesions in Crohn’s Disease
Quinn AM, Farraye FA,Niani B, Cerda S, Coukos J, Odze RD, Inflamm Bowel Dis, 5/1/2013
Significance of Granulomatous Inflammation Found on Endoscopic Biopsies or Surgical Resections on the Severity of Crohn’s Disease
Kanneganti M, Dehghani B, Steinberg J, Cerda S, Rybin D, Weinberg J, Farraye FA, J Clin Gastroenterol, 4/29/2013
Risk of Pneumocystis Jiroveci Pneumonia among Patients with Inflammatory Bowel Disease
Long MD, Farraye FA, Okafor P, Martin C, Sandler RS, Kappleman MD, Inflamm Bowel Dis, 4/1/2013
B Cell Secretion of Eotaxin-1 Modulates Eosinophil Function in Human Inflammatory Bowel Disease
Rehman MQ, Beal D, Liang YM, Noronha A, Winter H, Farraye FA, Ganley-Leal L, Inflamm Bowel Dis, 4/1/2013
Pyostomatitis Vegetans in a Patient with Fistulizing Crohn's Disease
Kalman RS, Gjede JM, Farraye FA, Clin Gastroenterol Hepatol, 3/20/2013
Gender and Location of CRC in IBD: Implications for Surveillance Protocols
Kwah J. Ditelberg JS, Farraye FA, Inflamm Bowel Dis, 3/1/2013
Pneumocystis Jiroveci Pneumonia in Inflammatory Bowel Disease Patients: A Survey of Prophylaxis Patterns among Gastroenterology Providers
Okafor P, Wasan, SK, Farraye FA, Inflamm Bowel Dis, 3/1/2013
Vitamin D Deficiency and Insufficiency Are Common in Ulcerative Colitis Patients after Ileal Pouch-anal Anastomosis
Miller HL, Farraye FA, Coukos JA, Howard LA, Stucchi AF, Holick MF, Becker JM, Inflamm Bowel Dis, 2/1/2013
Portal Venous Gas following Colonoscopy in Two Patients with Crohn’s Disease
Rao S, Tkacz JN, Farraye FA, Gastrointest Endosc, 2/1/2013
Factors That Affect Adherence to Surveillance Colonoscopy in Patients with Inflammatory Bowel Disease
Friedman S, Cheifetz AS, Farraye FA, Banks PA, Makrauer FL, Burakoff R, Farmer B, Torgersen LN, Wahl KE, Inflamm Bowel Dis, 1/1/2013
Doctor Message Can Alter Patients’ Behavior and Attitudes regarding Inflammatory Bowel Disease and Colon Cancer
Friedman S, Cheifetz AS, Farraye FA, Banks PA, Makrauer FL, Burakoff R, Farmer B, Torgersen LN, Wahl KE, Inflamm Bowel Dis, 8/1/2012
Capillary Hemangioma of the Esophagus in a Patient with Systemic Sclerosis and Watermelon Stomach
Roehrl MA, Farraye FA, Gastrointest Endosc, 8/1/2012
ASCA-IgG and CBir Antibodies Are Associated with the Development of Postoperative Crohn’s Disease and Fistulae following Ileal Pouch-anal Anastomosis
Coukos JA, Howard LA, Weinburg JM, Becker JM, Stucchi AF, Farraye FA, Dig Dis Sci, 6/1/2012
Join now to see all

Lectures

Endoscopy in IBD
AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/7/2018
48th Annual Gastroenterology Update Treatment of Special Cases
Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Cleveland, Ohio - 11/8/2012

Other

Surveillance after colorectal cancer resection
Farraye FA, Moy B, Jacobson BC
http://www.uptodate.com/contents/surveillance-after-colorectal-cancer-resection
UpToDate, Wolters Kluwer Health - 2013-03-28

Press Mentions

Major Adverse Cardiovascular Events in Patients with IBD Taking Anti-TNF vs JAK Inhibitors: A Propensity Matched Cohort AnalysisOctober 30th, 2024
Correspondence to: Francis a. Farraye, MD, MSc, Professor of Medicine, Director of Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, 4500 San Pablo Road, 32224, Jacksonville, FL, USA, E-mail: Farraye.Francis@mayo.eduJune 14th, 2024
The Future Will Be Personalized: Accelerating Microbiome ResearchNovember 24th, 2022
Join now to see all